Literature DB >> 32992328

Epitope-Specific Antibody Responses to a Plasmodium falciparum Subunit Vaccine Target in a Malaria-Endemic Population.

DeAnna J Friedman-Klabanoff1, Mark A Travassos1, Olukemi O Ifeonu2, Sonia Agrawal1, Amed Ouattara1, Andrew Pike1, Jason A Bailey1, Matthew Adams1, Drissa Coulibaly3, Kirsten E Lyke1, Matthew B Laurens1, Shannon Takala-Harrison1, Bourema Kouriba3, Abdoulaye K Kone3, Ogobara K Doumbo3, Jigar J Patel4, Mahamadou A Thera3, Philip L Felgner5, John C Tan4, Christopher V Plowe1, Andrea A Berry1.   

Abstract

Circumsporozoite protein (CSP) coats the Plasmodium falciparum sporozoite surface and is a major malaria subunit vaccine target. We measured epitope-specific reactivity to field-derived CSP haplotypes in serum samples from Malian adults and children on a custom peptide microarray. Compared to children, adults showed greater antibody responses and responses to more variants in regions proximal to and within the central repeat region. Children acquired short-lived immunity to an epitope proximal to the central repeat region but not to the central repeat region itself. This approach has the potential to differentiate immunodominant from protective epitope-specific responses when combined with longitudinal infection data.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Plasmodium falciparumzzm321990 ; circumsporozoite protein; malaria; peptide microarray

Mesh:

Substances:

Year:  2021        PMID: 32992328      PMCID: PMC8176638          DOI: 10.1093/infdis/jiaa611

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Binding and invasion of liver cells by Plasmodium falciparum sporozoites. Essential involvement of the amino terminus of circumsporozoite protein.

Authors:  Dharmendar Rathore; John B Sacci; Patricia de la Vega; Thomas F McCutchan
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

2.  The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria.

Authors:  Christopher V Plowe; Pedro Alonso; Stephen L Hoffman
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

3.  RTS,S malaria vaccine pilots in three African countries.

Authors:  Paul Adepoju
Journal:  Lancet       Date:  2019-04-27       Impact factor: 79.321

4.  A field trial to assess a blood-stage malaria vaccine.

Authors:  Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Matthew B Laurens; Amed Ouattara; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Idrissa Traore; Bourema Kouriba; Dapa A Diallo; Issa Diarra; Modibo Daou; Amagana Dolo; Youssouf Tolo; Mahamadou S Sissoko; Amadou Niangaly; Mady Sissoko; Shannon Takala-Harrison; Kirsten E Lyke; Yukun Wu; William C Blackwelder; Olivier Godeaux; Johan Vekemans; Marie-Claude Dubois; W Ripley Ballou; Joe Cohen; Darby Thompson; Tina Dube; Lorraine Soisson; Carter L Diggs; Brent House; David E Lanar; Sheetij Dutta; D Gray Heppner; Christopher V Plowe
Journal:  N Engl J Med       Date:  2011-09-15       Impact factor: 91.245

5.  Unexpected fold in the circumsporozoite protein target of malaria vaccines.

Authors:  Michael B Doud; Adem C Koksal; Li-Zhi Mi; Gaojie Song; Chafen Lu; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

Review 6.  The RTS,S malaria vaccine.

Authors:  Sofia Casares; Teodor-Doru Brumeanu; Thomas L Richie
Journal:  Vaccine       Date:  2010-05-27       Impact factor: 3.641

7.  A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling.

Authors:  Greg C Imholte; Renan Sauteraud; Bette Korber; Robert T Bailer; Ellen T Turk; Xiaoying Shen; Georgia D Tomaras; John R Mascola; Richard A Koup; David C Montefiori; Raphael Gottardo
Journal:  J Immunol Methods       Date:  2013-06-13       Impact factor: 2.303

Review 8.  The Promise of a Malaria Vaccine-Are We Closer?

Authors:  Matthew B Laurens
Journal:  Annu Rev Microbiol       Date:  2018-09-08       Impact factor: 15.500

9.  Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali.

Authors:  Drissa Coulibaly; Mark A Travassos; Abdoulaye K Kone; Youssouf Tolo; Matthew B Laurens; Karim Traore; Issa Diarra; Amadou Niangaly; Modibo Daou; Ahmadou Dembele; Mody Sissoko; Bouréima Guindo; Raymond Douyon; Aldiouma Guindo; Bourema Kouriba; Mahamadou S Sissoko; Issaka Sagara; Christopher V Plowe; Ogobara K Doumbo; Mahamadou A Thera
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

10.  Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.

Authors:  Mahamadou A Thera; Ogobara K Doumbo; Drissa Coulibaly; Dapa A Diallo; Abdoulaye K Kone; Ando B Guindo; Karim Traore; Alassane Dicko; Issaka Sagara; Mahamadou S Sissoko; Mounirou Baby; Mady Sissoko; Issa Diarra; Amadou Niangaly; Amagana Dolo; Modibo Daou; Sory I Diawara; D Gray Heppner; V Ann Stewart; Evelina Angov; Elke S Bergmann-Leitner; David E Lanar; Sheetij Dutta; Lorraine Soisson; Carter L Diggs; Amanda Leach; Alex Owusu; Marie-Claude Dubois; Joe Cohen; Jason N Nixon; Aric Gregson; Shannon L Takala; Kirsten E Lyke; Christopher V Plowe
Journal:  PLoS One       Date:  2008-01-23       Impact factor: 3.240

View more
  1 in total

1.  Plasmodium falciparum serology: A comparison of two protein production methods for analysis of antibody responses by protein microarray.

Authors:  Tate Oulton; Joshua Obiero; Isabel Rodriguez; Isaac Ssewanyana; Rebecca A Dabbs; Christine M Bachman; Bryan Greenhouse; Chris Drakeley; Phil L Felgner; Will Stone; Kevin K A Tetteh
Journal:  PLoS One       Date:  2022-08-29       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.